NYSE:TDOCTeladoc Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Teladoc Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $191.98 +6.89 (+3.72 %) (As of 08/13/2020 04:00 PM ET) Add Compare Share Today's Range$185.10Now: $191.98▼$198.1050-Day Range$183.75MA: $213.37▼$249.4252-Week Range$54.58Now: $191.98▼$253.00Volume140,401 shsAverage Volume3.15 million shsMarket Capitalization$15.59 billionP/E RatioN/ADividend YieldN/ABeta0.52 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Teladoc Health, Inc. provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers, health plans, health systems, and other entities in approximately 100 countries worldwide. Teladoc Health, Inc. has a collaboration with Cincinnati Children's Hospital Medical Center to develop a consumer pediatric telehealth platform. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.Read More Beat the Market (BTM) Rank™ 2.3 Analyst's Opinion Consensus RatingTeladoc Health has received a consensus rating of Buy. The company's average rating score is 2.54, and is based on 15 buy ratings, 13 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $198.67, Teladoc Health has a potential upside of 3.9% from its current price of $191.21.Amount of Analyst CoverageTeladoc Health has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.6 Community Rank Outperform VotesTeladoc Health has received 566 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTeladoc Health has received 507 “underperform” votes. (Add your “underperform” vote.)Community SentimentTeladoc Health has received 52.75% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Teladoc Health and other stocks. Vote “Outperform” if you believe TDOC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTeladoc Health does not currently pay a dividend.Dividend GrowthTeladoc Health does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $36,994,032.00 in company stock.Percentage Held by InsidersOnly 3.42% of the stock of Teladoc Health is held by insiders.Percentage Held by Institutions97.14% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Teladoc Health are expected to grow in the coming year, from ($1.42) to ($0.66) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Teladoc Health is -149.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Teladoc Health is -149.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTeladoc Health has a P/B Ratio of 13.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.30 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Offices & clinics of medical doctors Sub-IndustryN/A SectorMedical Current SymbolNYSE:TDOC Previous Symbol CUSIPN/A CIK1477449 Webwww.teladochealth.com Phone203-635-2002Debt Debt-to-Equity Ratio0.73 Current Ratio11.36 Quick Ratio11.36Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$553.31 million Price / Sales28.18 Cash FlowN/A Price / Cash FlowN/A Book Value$14.01 per share Price / Book13.70Profitability EPS (Most Recent Fiscal Year)($1.49) Net Income$-98,860,000.00 Net Margins-13.22% Return on Equity-9.54% Return on Assets-5.71%Miscellaneous Employees2,400 Outstanding Shares81,228,000Market Cap$15.59 billion Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $191.98 +6.89 (+3.72 %) (As of 08/13/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive TDOC News and Ratings via Email Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter. Teladoc Health (NYSE:TDOC) Frequently Asked Questions How has Teladoc Health's stock price been impacted by Coronavirus? Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have increased by 39.7% and is now trading at $191.98. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Teladoc Health? 28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teladoc Health. When is Teladoc Health's next earnings date? Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Teladoc Health. How were Teladoc Health's earnings last quarter? Teladoc Health Inc (NYSE:TDOC) posted its quarterly earnings data on Wednesday, July, 29th. The health services provider reported ($0.34) EPS for the quarter, missing the Zacks' consensus estimate of ($0.23) by $0.11. The health services provider had revenue of $241.03 million for the quarter, compared to analysts' expectations of $220.49 million. Teladoc Health had a negative net margin of 13.22% and a negative return on equity of 9.54%. The firm's revenue was up 85.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.41) EPS. View Teladoc Health's earnings history. What guidance has Teladoc Health issued on next quarter's earnings? Teladoc Health issued an update on its FY20 earnings guidance on Wednesday, July, 29th. The company provided earnings per share (EPS) guidance of ($1.45-1.36) for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.97). The company issued revenue guidance of $980-995 million, compared to the consensus revenue estimate of $872.82 million. What price target have analysts set for TDOC? 28 Wall Street analysts have issued 12 month price objectives for Teladoc Health's shares. Their forecasts range from $80.00 to $282.00. On average, they expect Teladoc Health's share price to reach $198.67 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price. View analysts' price targets for Teladoc Health. Has Teladoc Health been receiving favorable news coverage? Press coverage about TDOC stock has been trending extremely negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Teladoc Health earned a media sentiment score of -4.1 on InfoTrie's scale. They also assigned news stories about the health services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about Teladoc Health. Are investors shorting Teladoc Health? Teladoc Health saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 8,690,000 shares, a drop of 13.4% from the April 15th total of 10,040,000 shares. Based on an average daily volume of 3,530,000 shares, the short-interest ratio is presently 2.5 days. View Teladoc Health's Short Interest. Who are some of Teladoc Health's key competitors? Some companies that are related to Teladoc Health include Takeda Pharmaceutical (TAK), Bayer (BAYN), Humana (HUM), Boston Scientific (BSX), Illumina (ILMN), Edwards Lifesciences (EW), LONZA GRP AG/ADR (LZAGY), Biogen (BIIB), HCA Healthcare (HCA), Baxter International (BAX), Siemens Healthineers (SHL), DexCom (DXCM), RESMED/IDR UNRESTR (RMD), Centene (CNC) and COLOPLAST A/S/ADR (CLPBY). View all competitors. What other stocks do shareholders of Teladoc Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), salesforce.com (CRM), Square (SQ), Netflix (NFLX), Paypal (PYPL), Walt Disney (DIS) and Trade Desk (TTD). Who are Teladoc Health's key executives? Teladoc Health's management team includes the following people: Mr. Jason Nathanial Gorevic, CEO & Director (Age 47)Mr. Peter A. McClennen, Pres & Interim COO (Age 50)Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 44)Ms. Stephany Verstraete, Chief Marketing Officer (Age 50)Dr. George Byron Brooks BS EE, M.D., Co-Founder When did Teladoc Health IPO? (TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers. What is Teladoc Health's stock symbol? Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC." Who are Teladoc Health's major shareholders? Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Jennison Associates LLC (4.52%), Ensign Peak Advisors Inc (1.28%), First Trust Advisors LP (1.34%), Goldman Sachs Group Inc. (1.15%), Riverbridge Partners LLC (0.84%) and Blair William & Co. IL (0.69%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health. Which institutional investors are selling Teladoc Health stock? TDOC stock was sold by a variety of institutional investors in the last quarter, including Nicholas Investment Partners LP, Macquarie Group Ltd., Ensign Peak Advisors Inc, Riverbridge Partners LLC, Westwood Management Corp IL, Federated Hermes Inc., SG Americas Securities LLC, and Tygh Capital Management Inc.. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health. Which institutional investors are buying Teladoc Health stock? TDOC stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, First Trust Advisors LP, Goldman Sachs Group Inc., Sumitomo Mitsui Trust Holdings Inc., Swiss National Bank, Zweig DiMenna Associates LLC, Scout Investments Inc., and State Board of Administration of Florida Retirement System. View insider buying and selling activity for Teladoc Health. How do I buy shares of Teladoc Health? Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Teladoc Health's stock price today? One share of TDOC stock can currently be purchased for approximately $191.98. How big of a company is Teladoc Health? Teladoc Health has a market capitalization of $15.59 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe. What is Teladoc Health's official website? The official website for Teladoc Health is www.teladochealth.com. How can I contact Teladoc Health? Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected] This page was last updated on 8/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
